Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that the United States Patent and Trademark Office (USPTO) issued to ...

Its property of immunomodulation places it in effective use for diseases caused by sexual infections. Solosec (Secnidazole): Lupin Solosec (Secnidazole) is a nitroimidazole antibiotic that works well ...

The allowed patent application is directed to treatment of Trichomonas vaginalis infections (trichomoniasis) with SOLOSEC® (secnidazole) 2 g oral granules, with broad claims centered on ...

Despite numerous therapeutic research efforts, treatment of BV remains cumbersome and clinicians are currently rather poorly armed to treat BV properly in the long run. Moreover, appraisal of the ...

fluconazole–azithromicin–secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial.

SAN DIEGO, Feb. 13, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that the United States Patent and Trademark Office (USPTO) issued to the Company a Notice of ...